ribavirin (oral)


(rye ba VYE rin)
Copegus, Rebetol


What is the most important information I should know about ribavirin?
Ribavirin should not be used alone in the treatment of hepatitis C. It should be used in combination with an interferon alfa product. When used by itself, ribavirin is not effective against the hepatitis C virus.
Ribavirin is in the FDA pregnancy category X. This means that it is known to cause birth defects in an unborn baby. Ribavirin should not be used by women who are pregnant or by male partners of pregnant women. Treatment with ribavirin should not be started until a negative pregnancy test has been obtained. Extreme care must be taken to avoid pregnancy during treatment with ribavirin and for 6 months following the completion of treatment in women taking this medication and women partners of men being treated with this medication. Women who could become pregnant during treatment and men must use two reliable forms of birth control during treatment and during the 6-month period following treatment. A pregnancy test should be taken before starting treatment with ribavirin, every month during treatment, and every month for six months following treatment to make sure there is no pregnancy. Notify your doctor immediately if pregnancy occurs.
Ribavirin may cause anemia, which is a decrease in the number of red blood cells in the body. This can be dangerous, especially for patients who already have heart or circulatory problems. Your doctor will want to check your red blood cell count before starting treatment and periodically during treatment. Notify your doctor if you experience unusual tiredness, chest pain, or shortness of breath. These may be signs of low red blood cell counts.
Combination treatment with ribavirin and interferon alfa may cause mental health problems such as depression, suicidal behavior, and psychosis (loss of contact with reality such as hearing voices or seeing things that are not there). In general, these feelings and behaviors stop after treatment is stopped. Talk to your doctor immediately if you experience any new or worsening mental health problems.


What is ribavirin?
Ribavirin is an antiviral medication. The exact way that ribavirin works is unknown.
Ribavirin is used in combination with an interferon alfa product to treat chronic hepatitis C in patients with compensated liver disease who have not previously been treated with alfa interferon or who have relapsed following alfa interferon therapy.
Ribavirin may also be used for purposes other than those listed here.


What should I discuss with my healthcare provider before taking ribavirin?
Do not take ribavirin without first talking to your doctor if you have
     · a history of heart disease, high blood pressure, or a heart attack;
     · a hemoglobin disorder such as anemia (low red blood cell count), thalassemia (Mediterranean anemia), or sickle-cell anemia;
     · pancreatitis;
     · kidney problems;
     · liver problems (other than hepatitis C infection);
     · mental health problems such as depression or anxiety;
     · a history of organ transplant;
     · thyroid disease;
     · current or history of alcoholism or drug abuse or addiction;
     · cancer;
     · infection with hepatitis B virus and/or human immunodeficiency virus (HIV or AIDS);
     · diabetes; or
     · past interferon treatment for hepatitis C virus infection that did not work for you.
You may not be able to take ribavirin or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.
Ribavirin is in the FDA pregnancy category X. This means that it is known to cause birth defects in an unborn baby. Ribavirin should not be used by women who are pregnant or by male partners of pregnant women. Treatment with ribavirin should not be started until a negative pregnancy test has been obtained. Extreme care must be taken to avoid pregnancy during treatment with ribavirin and for 6 months following the completion of treatment in women taking this medication and women partners of men being treated with this medication. Women who could become pregnant during treatment and men must use two reliable forms of birth control during treatment and during the 6-month period following treatment. A pregnancy test should be taken before starting treatment with ribavirin, every month during treatment, and every month for six months following treatment to make sure there is no pregnancy. Notify your doctor immediately if pregnancy occurs.
It is not known whether ribavirin passes into breast milk. Because it may harm a nursing baby, breast-feeding is not recommended during treatment with ribavirin.
Side effects may be more likely to occur in people over the age of 65 treated with ribavirin. A lower dose or special monitoring may be required.


How should I take ribavirin?
Take ribavirin exactly as directed by your doctor. If you do not understand these instructions, ask your doctor, nurse, or pharmacist to explain them to you.
Ribavirin should not be used alone in the treatment of hepatitis C. It should be used in combination with an interferon alfa product. When used by itself, ribavirin is not effective against the hepatitis C virus.
Take the ribavirin tablets and capsules with a full glass of water.
To ensure that you get a correct dose, measure the ribavirin solution with a dose-measuring spoon, dropper, or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.
Take the medication twice a day in the morning and evening as directed by your doctor. It is recommended that ribavirin be taken with food. However, ribavirin can be taken with or without food. It should be taken the same way every day (e.g., with food or without food).
Maintain adequate fluid intake to prevent dehydration during treatment with ribavirin by drinking several extra glasses of fluid each day. Additional fluid may be necessary during hot weather, vigorous exercise, and illness.
It is important to follow your dosing schedule and your health care provider's instructions on how to take your medicines.
Take the medicine for as long as it is prescribed and do not take more than the recommended dose.
It is important to take ribavirin regularly to get the most benefit.
Your doctor may want you to have regularly scheduled blood tests or other medical evaluations during treatment with ribavirin to monitor progress and side effects.
Treatment with ribavirin does not prevent spread of the hepatitis C virus to other people. Follow your healthcare provider's instructions regarding minimizing the risk of spreading the virus.
Store ribavirin tablets and capsules at room temperature away from moisture, heat, and light.
The ribavirin oral solution can be stored at room temperature, away heat and light, or in the refrigerator.


What happens if I miss a dose?
If you miss a dose of ribavirin, take the missed dose as soon as possible during the same day. If an entire day has gone by, check with your health care provider about what to do. Do not double the next dose.


What happens if I overdose?
Seek emergency medical attention if an overdose is suspected.
Symptoms of a ribavirin overdose are not known.


What should I avoid while taking ribavirin?
Do not drink alcohol during treatment with ribavirin unless otherwise directed by your doctor.
Do not take other prescription or nonprescription drugs, including herbal products during treatment with ribavirin without first talking to your doctor.
Maintain adequate fluid intake to prevent dehydration during treatment with ribavirin by drinking several extra glasses of fluid each day. Additional fluid may be necessary during hot weather, vigorous exercise, and illness.
Use caution when driving, operating machinery, or performing other hazardous activities. Ribavirin may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities.
Treatment with ribavirin does not prevent spread of the hepatitis C virus to other people. Follow your healthcare provider's instructions regarding minimizing the risk of spreading the virus.


What are the possible side effects of ribavirin?
Stop taking ribavirin and seek emergency medical attention or call your doctor immediately if you experience
     · an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
     · chest, arm or neck pain;
     · trouble breathing or increased cough;
     · severe stomach pain or low back pain;
     · black or bloody bowel movements (may look like black tar);
     · unusual bruising or bleeding;
     · changes in vision;
     · fever greater than 100.5 degrees Fahrenheit; or
     · worsening symptoms of psoriasis.
Ribavirin may cause anemia, which is a decrease in the number of red blood cells in the body. This can be dangerous, especially for patients who already have heart or circulatory problems. Your doctor will want to check your red blood cell count before starting treatment and periodically during treatment. Notify your doctor if you experience unusual tiredness, chest pain, or shortness of breath. These may be signs of low red blood cell counts.
Combination treatment with ribavirin and interferon alfa may cause mental health problems such as depression, suicidal behavior, and psychosis (loss of contact with reality such as hearing voices or seeing things that are not there). In general, these feelings and behaviors stop after treatment is stopped. Talk to your doctor immediately if you experience any new or worsening mental health problems.
Other less serious side effect may be more likely to occur. Continue to take ribavirin and talk to your doctor if you experience
     · fatigue or tiredness;
     · nausea or decreased appetite;
     · thinning of the hair;
     · rash or itching; or
     · insomnia or restlessness.
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.


What other drugs will affect ribavirin?
Before taking ribavirin, tell your doctor if you are taking any other prescription or over-the-counter medicines, including vitamins, minerals, and herbal products, and do not start taking any other medicines during treatment without first talking to your doctor. You may require a dosage adjustment or special monitoring during treatment.


Where can I get more information?
Your pharmacist has additional information about ribavirin written for health professionals that you may read.


Remember, keep this and all other medicines out of the reach of children, never share your medicines with other, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2004 Cerner Multum, Inc. Version: 3.01. Revision date: 2/10/04.